M10.152
Lead-induced gout, left hip
Clinical Classification Guidelines
Medical Intelligence & Overview
Lead-induced gout is a form of gout caused by the buildup of lead in the body, leading to joint inflammation and pain, particularly in the left hip in this case. This condition is a type of secondary gout, meaning it results from other health issues or environmental exposures. It is characterized by joint swelling, pain, and sometimes tissue damage, caused by uric acid crystal deposits due to lead interference with normal metabolic processes.
Causes & Symptoms
Clinical Causes: Chronic exposure to lead through contaminated water, soil, or occupational settings such as battery manufacturing or construction work. Prolonged lead poisoning leading to increased uric acid levels in the blood. Impaired kidney function caused by lead toxicity, reducing uric acid clearance. Wear and tear of joints due to constant inflammation triggered by lead deposits complemented by urate crystal formation.
Key Symptoms: Persistent pain and swelling in the left hip area. Joint stiffness and difficulty moving the affected hip. Tenderness upon touch around the joint. Increased warmth and redness over the joint. Possible development of tophi—small, chalky deposits of uric acid crystals around the joint or tissues. General fatigue or malaise if lead poisoning is severe.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history, physical examination, and specific tests such as:
Treatment Protocols: Managing lead-induced gout typically focuses on reducing lead levels and alleviating joint symptoms. Treatment approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M10.152 a billable ICD-10 code?
Yes, M10.152 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.152?
Clinical documentation must specify the nature of Lead-induced gout, left hip and any associated comorbidities for accurate reporting.
Cite this Clinical Reference